Delivery Order SPE2DB22D1106-SPE2DB24FEZQ7
Award Date
6/28/24
Potential Completion Date
7/1/24
Potential Value
$3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $7,081.13, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Ketorolac 0.5% ophthalmic solution, a prescription eye drop medication, with a performance period through February 3, 2025. The contract is not designated as a set-aside and was awarded under an existing Indefinite Delivery Contract (IDC) held by...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of ketorolac 0.5% ophthalmic solution in 10 ml bottles. The $3,564.79 Firm Fixed Price Delivery Order was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense, on April 15, 2024, with a planned completion date of April 16, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of Ketorolac 0.4% ophthalmic solution, a prescription eye medication, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on a firm fixed-price basis for a total ceiling value of $2,047.08. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 2025. This...
This federal contract award, with an identifier of SPE2DB22D3016|SPE2DB24FBDJ4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Ketorolac 0.4% ophthalmic solution, a medication used to treat eye pain and inflammation. It is a firm-fixed-price delivery order contract with a ceiling value of $1,114.09 and a completion date of August 9, 2024. The contract does not have a set-aside designation....
This federal contract award for $1,619.20 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a ceiling value of $1,619.20, is a delivery order to supply the DLA with 4,566,678,521 units of the medication Ketorolac 60 mg/2 ml vial. This contract award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,848.11 fixed-price contract is for the supply of Ketorolac 15 mg/mL vials, a medication used for pain management, to support military healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,499.84 firm fixed-price delivery order is for the supply of Ketorolac 30 mg/mL vials, a pain medication. The contract has an ultimate completion date of October 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $4,190.96, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award covers the delivery of Ketorolac 30 mg/mL vials, a medication used for pain management. The contract is a firm fixed-price delivery order with a completion date of November 21, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The $1,206.54 Firm Fixed Price Delivery Order is for the supply of Ketorolac 30 mg/ml vials, a prescription pain medication. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for the company...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract valued at $7,542.83 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4564247323 - Ketorolac 0.5% Ophthalmic Solution 5ML. The contract has an ultimate completion date of April 12, 2024. This delivery order is issued under Amerisourcebergen's single-award indefinite delivery contract with DLA valued up to $999,999,999.00 through December 31, 2025, which serves...